Unexplained weight loss (UWL) remains a clinical conundrum, often signaling underlying systemic disorders. It is incumbent upon clinicians to adopt a comprehensive approach to this multifaceted issue.
UWL is typically defined as a loss of more than 5% of body weight over a period of 6-12 months without a clear etiology. It's a common symptom in various diseases, including malignancies, endocrine disorders, gastrointestinal diseases, and psychiatric conditions.
History-taking and physical examination are paramount in the initial evaluation. The former should focus on dietary habits, gastrointestinal symptoms, changes in taste or smell, and medication use. The latter should be comprehensive, with particular attention to signs of cachexia, lymphadenopathy, and abdominal masses.
Initial laboratory investigations should include complete blood count, metabolic panel, liver function tests, thyroid function tests, and inflammatory markers. If these are inconclusive, imaging studies, endoscopy, and biopsy may be warranted. It's crucial to consider the patient's age, associated symptoms, and risk factors while planning the diagnostic approach.
Management should be etiology-specific and may involve treating the underlying disease, nutritional support, or pharmacotherapy. In cases where no clear cause is found, a symptom-based approach, regular follow-up, and reassessment are essential.
UWL is a complex clinical entity that requires a comprehensive, patient-centered approach. A meticulous history, thorough physical examination, and judicious use of diagnostic tests are key to identifying the underlying cause. Management should be tailored to the specific etiology, with a focus on addressing the patient's symptoms and improving their quality of life.
1.
A Lot Can Be Said About You by Including Yourself in Photos.
2.
A new blood test greatly increases the ability to detect cancer.
3.
Novel biomarker has potential for predicting and treating skin cancer metastasis
4.
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC
5.
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer
1.
Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy
2.
Preventing Treatment-Related Secondary Malignancies: Evidence-Based Strategies for Clinical Practice
3.
Contemporary Frameworks in Oncology Across Clinical Settings
4.
What is Mullerian and How Does it Affect Your Health
5.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding Common Causes of Abnormal Blood Counts
2.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Understanding Cancer: Early Detection and Treatment
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation